Skip to main content
OpenTrials

Clinical trial condition

Metabolism, Inborn Errors

Explore clinical trials studying Metabolism, Inborn Errors. Study availability and eligibility vary by location and protocol.

2,499 public trials 456 recruiting studies
Refine in advanced search Browse all conditions

Metabolism, Inborn Errors trial results

Completed

Does Daily Supplementation of Lactobacillus Acidophilus MPH734, for One Week, Affect Acute (Immediate), Subacute (7 Days), and Post-treatment Discontinuation Lactose Metabolism, Gastrointestinal Symptoms, and Clinical Markers of Inflammation and Safety Compared to a Placebo

NCT04531033

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +8 more
Locations
  • University of Mary Hardin-Baylor Belton, Texas, United States
View Trial Details
Completed

MRI QSM Imaging for Iron Overload

NCT04631718

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Hemochromatosis, +6 more
Locations
  • School of Medicine, Stanford University Stanford, California, United States
  • University of Wisconsin Madison, Wisconsin, United States
View Trial Details
Completed

Breakfast for Young Women

NCT04652713

Conditions
Body Weight, Cholesterol Ester Storage Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +17 more
Locations
  • Aarhus University, Department for Public Health, Section for Sport Science Aarhus, Denmark
View Trial Details
Completed

Decision Support for Parents Receiving Information About Child's Rare Disease

NCT01875640

Conditions
Adrenal Gland Diseases, Adrenal Hyperplasia, Congenital, Adrenogenital Syndrome, +23 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • Temple University Philadelphia, Pennsylvania, United States
  • Seattle Children's Hospital Seattle, Washington, United States
View Trial Details
Completed

Long-Term Extension Study of KRN23 in Adult Subjects With X-Linked Hypophosphatemia (XLH)

NCT02312687

Conditions
Avitaminosis, Bone Diseases, Bone Diseases, Metabolic, +26 more
Locations
  • University California San Francisco Hospital San Francisco, California, United States
  • Yale University School of Medicine New Haven, Connecticut, United States
  • Indiana University Hospital Indianapolis, Indiana, United States
  • Duke University Durham, North Carolina, United States
View Trial Details
Completed

Study of KRN23 (Burosumab), a Recombinant Fully Human Monoclonal Antibody Against Fibroblast Growth Factor 23 (FGF23), in Pediatric Subjects With X-linked Hypophosphatemia (XLH)

NCT02163577

Conditions
Avitaminosis, Bone Diseases, Bone Diseases, Metabolic, +26 more
Locations
  • University of California San Francisco San Francisco, California, United States
  • Yale University School of Medicine New Haven, Connecticut, United States
  • Indiana University Hospital Indianapolis, Indiana, United States
  • Shriners Hospital for Children St Louis, Missouri, United States
View Trial Details

Related conditions